Abstract
Current discussions about cost-effectiveness in the field of medical devices for cardiology are reviewed. In order to identify the trends, we performed a review of studies published in medical journals. After having reviewed 1143 originally identified papers, we finally selected 61 papers to be studied in detail. The selected papers are classified into two categories: diagnostic and therapeutic medical devices, while technology for telemedicine is briefly mentioned. In each category, cost-effectiveness results of chosen modalities are presented. The main trend seems to be avoiding invasive technology during the treatment. This trend is obvious both in the field of diagnostic and therapeutic devices. In CAD diagnostics, some authors try to prove that CT, PET or SPECT are more cost-effective than ICA. As compared with the classical (open chest) surgery in the past, the treatment of cardio-vascular illnesses is moving to less invasive interventions (TAVI versus SAVR is just one example).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Blaha, M.J., et al.: Heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation 129, e28–e292 (2014)
WHO: World Health Organization, http://www.who.int
Odden, M.C., Coxson, P.G., Moran, A., Lightwood, J.M., Goldman, L., Bibbins-Domingo, K.: The impact of the Aging Population on Coronary Heart Disease in the U.S. The American Journal of Medicine 124,827–833 (2012)
Nichols, M., Townsend, N., Luengo-Fernandez, R., Leal, J., Gray, A., Scarborough, P., Rayner, M.: European Cardiovascular Disease Statistics 2012. European Heart Network and European Society of Cardiology, Brussels and Sophia Antipolis (2012)
Drummond, M., Griffin, A., Tarricone, R.: Economic evaluation for devices and drugs, same or different? Value in Health 12, 402–404 (2009)
Rosina, J., Rogalewicz, V., Ivlev, I., Juřičková, I., Donin, G., Jantosová, N., Vacek, J., Otawová, R., Kneppo, P.: Health Technology Assessment for Medical Devices. Lekar a Technika - Clinician and Technology 44, 23–36 (2014)
Rogalewicz, V., Jurickova, I.: Specificities of Medical Devices Affecting Health Technology Assessment Methodology. Proceedings Iwbbio 2014: International Work-Conference on Bioinformatics and Biomedical Engineering, vols. 1 and 2, pp. 1229–1234 (2014)
Giraldes, M.D.R.: Evaluation of New Technologies PET/CT Nuclear Imaging. Acta Medica Portuguesa 23, 291–310 (2010)
Hachamovitch, R., Johnson, J.R., Hlatky, M.A., Cantagallo, L., Johnson, B.H., Coughlan, M., Hainer, J., Gierbolini, J., di Carli, M.F., Investigators, S.: The study of myocardial perfusion and coronary anatomy imaging roles in CAD (SPARC): design, rationale, and baseline patient characteristics of a prospective, multicenter observational registry comparing PET, SPECT, and CTA for resource utilization and cl. Journal of Nuclear Cardiology 16, 935–948 (2009)
Meyer, M., Nance, J.W.J., Schoepf, U.J., Moscariello, A., Weininger, M., Rowe, G.W., Ruzsics, B., Kang, D.K., Chiaramida, S.A., Schoenberg, S.O., Fink, C., Henzler, T.: Cost-effectiveness of substituting dual-energy CT for SPECT in the assessment of myocardial perfusion for the workup of coronary artery disease. European Journal of Radiology 81, 3719–3725 (2012)
Pelberg, R.A., Mazur, W., Clarke, G., Szawaluk, J.: The What and Why of Cardiac CT Angiography: Data Interpretation and Clinical Practice Integration. Reviews in Cardiovascular Medicine 10, 152–163 (2009)
Mowatt, G., Cummins, E., Waugh, N., Walker, S., Cook, J., Jia, X., Hillis, G., Fraser, C.: Systematic review of the clinical effectiveness and cost-effectiveness of 64-slice or higher computed tomography angiography as an alternative to invasive coronary angiography in the investigation of coronary artery disease. Health Technology Assessment 12(17) (2008)
Catalan, P., Callejo, D., Juan, A.B.: Cost-effectiveness analysis of 64-slice computed tomography vs. cardiac catheterization to rule out coronary artery disease before non-coronary cardiovascular surgery. European Heart Journal-Cardiovascular Imaging 14, 149–156 (2013)
Dorenkamp, M., Bonaventura, K., Sohns, C., Becker, C.R., Leber, A.W.: Direct costs and cost-effectiveness of dual-source computed tomography and invasive coronary angiography in patients with an intermediate pretest likelihood for coronary artery disease. Heart 98, 460–467 (2012)
Ladapo, J.A., Jaffer, F.A., Hoffmann, U., Thomson, C.C., Bamberg, F., Dec, W., Cutler, D.M., Weinstein, M.C., Gazelle, G.S.: Clinical outcomes and cost-effectiveness of coronary computed tomography angiography in the evaluation of patients with chest pain. Journal of the American College of Cardiology 54, 2409–2422 (2009)
Dewey, M., Hamm, B.: Cost effectiveness of coronary angiography and calcium scoring using CT and stress MRI for diagnosis of coronary artery disease. European Radiology 17, 1301–1309 (2007)
Halpern, E.J., Savage, M.P., Fischman, D.L., Levin, D.C.: Cost-effectiveness of coronary CT angiography in evaluation of patients without symptoms who have positive stress test results. American Journal of Roentgenology 194, 1257–1262 (2010)
Kreisz, F.P., Merlin, T., Moss, J., Atherton, J., Hiller, J.E., Gericke, C.A.: The pre-test risk stratified cost-effectiveness of 64-slice computed tomography coronary angiography in the detection of significant obstructive coronary artery disease in patients otherwise referred to invasive coronary angiography. Heart, Lung & Circulation 18, 200–207 (2009)
Stacul, F., Sironi, D., Grisi, G., Belgrano, M., Salvi, A., Cova, M.: 64-Slice CT coronary angiography versus conventional coronary angiography: activity-based cost analysis. Radiologia Medica 114, 239–252 (2009)
Min, J.K., Gilmore, A., Budoff, M.J., Berman, D.S., O’Day, K.: Cost-effectiveness of coronary CT angiography versus myocardial perfusion SPECT for evaluation of patients with chest pain and no known coronary artery disease. Radiology 254, 801–808 (2010)
Genders, T.S.S., Ferket, B.S., Dedic, A., Galema, T.W., Mollet, N.R.A., de Feyter, P.J., Fleischmann, K.E., Nieman, K., Hunink, M.G.M.: Coronary computed tomography versus exercise testing in patients with stable chest pain: comparative effectiveness and costs. International Journal of Cardiology 167, 1268–1275 (2013)
Nance, J.W., Bamberg, F., Schoepf, U.J.: Coronary computed tomography angiography in patients with chronic chest pain: systematic review of evidence base and cost-effectiveness. Journal of Thoracic Imaging 27, 277–288 (2012)
Fearon, W.F., Tonino, P.A.L., de Bruyne, B., Siebert, U., Pijls, N.H.J.: Rationale and design of the fractional flow reserve versus angiography for multivessel evaluation (FAME) study. American Heart Journal 154, 632–636 (2007)
Matchin, Y.G., Privalova, O.B., Privalov, D.V., Zateyshchikov, D.A., Boytsov, S.A.: New approach towards diagnostic coronarography at hospitals without their own angiography laboratories. Cardiovascular Therapy and Prevention 7, 51–57 (2008)
Miller, T.D., Hodge, D.O., Milavetz, J.J., Gibbons, R.J.: A normal stress SPECT scan is an effective gatekeeper for coronary angiography. Journal of Nuclear Cardiology 14, 187–193 (2007)
Le Guludec, D., Lautamaki, R., Knuuti, J., Bax, J., Bengel, F., Cardiology, E.C.N.: Present and future of clinical cardiovascular PET imaging in Europe - a position statement by the European Council of Nuclear Cardiology (ECNC). European Journal of Nuclear Medicine and Molecular Imaging 35, 1709–1724 (2008)
Marcassa, C., Bax, J.J., Bengel, F., Hesse, B., Petersen, C.L., Reyes, E., Underwood, R.: Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: a position statement. European Heart Journal 29, 557–563 (2008)
Shaw, L.J., Marwick, T.H., Berman, D.S., Sawada, S., Heller, G.V., Vasey, C., Miller, D.D.: Incremental cost-effectiveness of exercise echocardiography vs. SPECT imaging for the evaluation of stable chest pain. European Heart Journal 27, 2448–2458 (2006)
Papadakis, M., Sharma, S.: Electrocardiographic screening in athletes: the time is now for universal screening. British Journal of Sports Medicine 43, 663–668 (2009)
Borjesson, M., Dellborg, M.: Is There Evidence for Mandating Electrocardiogram as Part of the Pre-Participation Examination? Clinical Journal of Sport Medicine 21, 13–17 (2011)
Chandra, N., Rachel, B., Papadakis, M.F., Panoulas, V.F., Ghani, S., Dusche, J., Folders, D., Raju, H., Osborne, R., Sharma, S.: Prevalence of Electrocardiographic Anomalies in Young Individuals. Journal of the American College of Cardiology 63, 2028–2034 (2014)
Anderson, B.R., McElligott, S., Polsky, D., Vetter, V.L.: Electrocardiographic Screening for Hypertrophic Cardiomyopathy and Long QT Syndrome: The Drivers of Cost-Effectiveness for the Prevention of Sudden Cardiac Death. Death. Pediatric Cardiology 35, 323–331 (2014)
Bedetti, G., Pasanisi, E.M., Pizzi, C., Turchetti, G., Lore, C.: Economic analysis including long-term risks and costs of alternative diagnostic strategies to evaluate patients with chest pain. Cardiovascular Ultrasound 6(21) (2008)
Simpson, E.L., Stevenson, M.D., Scope, A., Poku, E., Minton, J., Evans, P.: Echocardiography in newly diagnosed atrial fibrillation patients: a systematic review and economic evaluation. Health Technology Assessment 17(36) (2013)
Kitada, R., Fukuda, S., Watanabe, H., Oe, H., Abe, Y., Yoshiyama, M., Song, J.-M., Sitges, M., Shiota, T., Ito, H., Yoshikawa, J.: Diagnostic Accuracy and Cost-Effectiveness of a Pocket-Sized Transthoracic Echocardiographic Imaging Device. Clinical Cardiology 36, 603–610 (2013)
Trambaiolo, P., Papetti, F., Posteraro, A., Amici, E., Piccoli, M., Cerquetani, E., Pastena, G., Gambelli, G., Salustri, A.: A hand-carried cardiac ultrasound device in the outpatient cardiology clinic reduces the need for standard echocardiography. Heart 93, 470–475 (2007)
Hales, A.R., Mahle, W.T.: Echocardiography Screening of Siblings of Children With Bicuspid Aortic Valve. Pediatrics 133,E1212–E1217 (2014)
Reardon, M.J., Reynolds, M.R.: Cost-effectiveness of TAVR in the non-surgical population. Journal of Medical Economics 16, 575–579 (2013)
Reynolds, M.R., Magnuson, E.A., Lei, Y., Wang, K., Vilain, K., Li, H., Walczak, J., Pinto, D.S., Thourani, V.H., Svensson, L.G., Mack, M.J., Miller, D.C., Satler, L.E., Bavaria, J., Smith, C.R., Leon, M.B., Cohen, D.J.: Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). Journal of the American College of Cardiology 60, 2683–2692 (2012)
Neyt, M., van Brabandt, H., Devriese, S., van de Sande, S.: A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ Open 2 (2012)
Fairbairn, T.A., Meads, D.M., Hulme, C., Mather, A.N., Plein, S., Blackman, D.J., Greenwood, J.P.: The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk. Heart 99, 914–920 (2013)
Doble, B., Blackhouse, G., Goeree, R., Xie, F.: Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective. Journal of Thoracic and Cardiovascular Surgery 146, 52–60.e53 (2013)
Blomstrom, P., Ekman, M., Lundqvist, C., Calvert, M.J., Freemantle, N., Lonnerholm, S., Wikstrom, G., Jonsson, B.: Cost effectiveness of cardiac resynchronization therapy in the Nordic region: An analysis based on the CARE-HF trial. European Journal of Heart Failure 10, 869–877 (2008)
Bertoldi, E.G., Rohde, L.E., Zimerman, L.I., Pimentel, M., Polanczyk, C.A.: Cost-effectiveness of cardiac resynchronization therapy in patients with heart failure: the perspective of a middle-income country’s public health system. International Journal of Cardiology 163, 309–315 (2013)
Neyt, M., Stroobandt, S., Obyn, C., Camberlin, C., Devriese, S.: se Laet, C., van Brabandt, H.: Cost-effectiveness of cardiac resynchronisation therapy for patients with moderate-to-severe heart failure: a lifetime Markov model. BMJ Open 1,e000276 (2011)
Fox, M., Mealing, S., Anderson, R., Dean, J., Stein, K., Price, A., Taylor, R.: The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model. Health Technology Assessment 11(47) (2007)
IKEM: Implantation of cardioverter-defibrilator (ICD) (in Czech), http://www.ikem.cz/www?docid=1004024
Boriani, G., Cimaglia, P., Biffi, M., Martignani, C., Ziacchi, M., Valzania, C., Diemberger, I.: Cost-effectiveness of implantable cardioverter-defibrillator in today’s world. Indian Heart Journal 66(suppl. 1), S101–104 (2014)
Garcia-Perez, L., Pinilla-Dominguez, P., Garcia-Quintana, A., Caballero-Dorta, E., Garcia-Garca, F.J., Linertova, R., Imaz-Iglesia, I.: Economic evaluations of implantable cardioverter defibrillators: a systematic review. European Journal of Health Economics (October 2014)
Smith, T., Jordaens, L., Theuns, D.A.M.J., van Dessel, P.F., Wilde, A.A., Hunink, M.G.M.: The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis. European Heart Journal 34, 211–219 (2013)
Gandjour, A., Holler, A., Adarkwah, C.C.: Cost-effectiveness of implantable defibrillators after myocardial infarction based on 8-year follow-up data (MADIT II). Value in Health 14, 812–817 (2011)
Vida, V.L., Calvimontes, G.S., Macs, M.O., Aparicio, P., Barnoya, J., Castaneda, A.R.: Radiofrequency catheter ablation of supraventricular tachycardia in children and adolescents - Feasibility and cost-effectiveness in a low-income country. Pediatric Cardiology 27, 434–439 (2006)
Wang, L.X., Li, J.T., Yao, R.G., Song, S.K.: Simplified approach to radiofrequency catheter ablation of paroxysmal supraventricular tachycardia. Croatian Medical Journal 45, 167–170 (2004)
Mishra, V., Svennevig, J.L., Bugge, J.F., Andresen, S., Mathisen, A., Karlsen, H., Khushi, I., Hagen, T.P.: Cost of extracorporeal membrane oxygenation: evidence from the Rikshospitalet University Hospital, Oslo, Norway. European Journal of Cardio-thoracic Surgery 37, 339–342 (2010)
Tseng, Y.H., Wu, M.Y., Tsai, F.C., Chen, H.J., Lin, P.J.: Costs Associated with Extracorporeal Life Support Used in Adults: A Single-Center Study. Acta Cardiologica Sinica 27, 221–228 (2011)
Roos, J.B., Doshi, S.N., Konorza, T., Palacios, I., Schreiber, T., Borisenko, O.V., Henriques, J.P.S.: The cost-effectiveness of a new percutaneous ventricular assist device for high-risk PCI patients: mid-stage evaluation from the European perspective. Journal of Medical Economics 16, 381–390 (2013)
Graf, J., Muhlhoff, C., Doig, G.S., Reinartz, S., Bode, K., Dujardin, R., Koch, K.-C., Roeb, E., Janssens, U.: Health care costs, long-term survival, and quality of life following intensive care unit admission after cardiac arrest. Critical Care 12,R92 (2008)
Clarke, A., Pulikottil-Jacob, R., Connock, M., Suri, G., Kandala, N.-B., Maheswaran, H., Banner, N.R., Sutcliffe, P.: Cost-effectiveness of left ventricular assist devices (LVADs) for patients with advanced heart failure: analysis of the British NHS bridge to transplant (BTT)program. International Journal of Cardiology 171, 338–345 (2014)
Mugford, M., Elbourne, D., Field, D.: Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants. The Cochrane Database of Systematic Reviews CD001340 (2008)
Petrou, S., Edwards, L.: Cost effectiveness analysis of neonatal extracorporeal membrane oxygenation based on four year results from the UK Collaborative ECMO Trial. Archives of Disease in Childhood. Fetal and Neonatal Edition 89, F263–F268 (2004)
Petrou, S., Bischof, M., Bennett, C., Elbourne, D., Field, D., McNally, H.: Cost-effectiveness of neonatal extracorporeal membrane oxygenation based on 7-year results from the United Kingdom Collaborative ECMO Trial. Pediatrics 117, 1640–1649 (2006)
de Waure, C., Cadeddu, C., Gualano, M.R., Ricciardi, W.: Telemedicine for the reduction of myocardial infarction mortality: a systematic review and a meta-analysis of published studies. Telemedicine and e-Health 18, 323–328 (2012)
Mistry, H., Gardiner, H.M.: The cost-effectiveness of prenatal detection for congenital heart disease using telemedicine screening. Journal of Telemedicine and Telecare 19, 190–196 (2013)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this paper
Cite this paper
Otawova, R., Kamensky, V., Hasenohrlova, P., Rogalewicz, V. (2015). Cost-Effectiveness Studies on Medical Devices: Application in Cardiology. In: Ortuño, F., Rojas, I. (eds) Bioinformatics and Biomedical Engineering. IWBBIO 2015. Lecture Notes in Computer Science(), vol 9043. Springer, Cham. https://doi.org/10.1007/978-3-319-16483-0_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-16483-0_16
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-16482-3
Online ISBN: 978-3-319-16483-0
eBook Packages: Computer ScienceComputer Science (R0)